CPT 83661: Fetal Lung Maturity Test, Lecithin:Sphingomyelin Ratio

CPT code 83661 represents a laboratory test that measures the lecithin:sphingomyelin (L/S) ratio to assess fetal lung maturity. This test is clinically significant when assessing readiness for delivery in pregnancies at risk for preterm birth or when elective delivery timing is being considered. Nationally, fetal lung–maturity testing informs perinatal management decisions and can affect neonatal outcomes and resource use.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the test, typical sites of service, and the common administrative elements that affect billing and claims processing for laboratory services. The publication outlines benchmark considerations for utilization and payer coverage patterns, highlights relevant policy or coding updates when available, and summarizes operational implications for laboratories and obstetric care teams. The report also explains typical modifiers and claim components used with lab services and indicates where input data were not available. This resource is intended for revenue cycle managers, laboratory directors, and clinicians seeking a concise national summary of CPT code 83661 and its role in perinatal care.

Billing Code Overview

CPT code 83661 describes a laboratory assay that assesses fetal lung maturity by measuring the lecithin:sphingomyelin (L/S) ratio. The test is used to evaluate whether the fetal pulmonary system has developed sufficiently to support life outside the uterus.

Service type: Laboratory service — fetal lung maturity testing

Typical site of service: Clinical laboratory or hospital laboratory (specimens collected in an inpatient or outpatient obstetric setting and analyzed in a lab)

Data not available in the input.

Clinical Context

A pregnant patient at risk for preterm delivery undergoes evaluation of fetal lung maturity. A maternal-fetal medicine specialist or obstetrician orders the lecithin:sphingomyelin (L/S) ratio test (83661) following collection of amniotic fluid via amniocentesis or when an amniotic fluid sample is available from clinical care. Typical indications include premature rupture of membranes, preterm labor, maternal medical conditions (for example, poorly controlled diabetes), or planned preterm delivery for maternal or fetal indications. The laboratory receives the amniotic fluid sample, the lab analyst performs the biochemical assay to calculate the lecithin to sphingomyelin ratio, and the result is reported to the ordering clinician to inform decisions about timing of delivery, need for corticosteroid administration, or neonatal respiratory support planning.

Coding Specifications

Modifier	Description	When to Use
`11`	Standard office or outpatient service	Use when this laboratory test is part of a routine outpatient prenatal evaluation billed under normal circumstances.
`26`

Taxonomy Code	Specialty	Notes
`207Q00000X`	Obstetrics & Gynecology	Ordering clinicians who commonly request fetal lung maturity testing.
`207RC0000X`	Maternal and Fetal Medicine	Specialists managing high-risk pregnancies who frequently order `83661`.
`207L00000X`	Pathology & Laboratory Medicine	Providers responsible for laboratory oversight and interpretation.
`207LP2900X`	Clinical Laboratory	Clinical laboratory directors and technicians performing the assay.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`O42.10`	Premature rupture of membranes, onset labor within 24 hours	PROM increases consideration of fetal lung maturity testing to guide timing of delivery.
`O42.90`	Premature rupture of membranes, unspecified, first trimester not applicable	PROM of uncertain timing may prompt assessment of fetal lungs when gestational age is borderline.
`O60.14`	Preterm labor, with preterm delivery, second trimester	Preterm labor situations commonly prompt L/S ratio testing when delivery timing is uncertain.
`O09.213`	Supervision of pregnancy with poor fetal growth, second trimester	Fetal growth restriction cases may require evaluation of lung maturity if early delivery is considered.
`O24.414`	Gestational diabetes mellitus in pregnancy, diet controlled, second trimester	Maternal diabetes can delay fetal lung maturity; L/S testing is clinically relevant.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`56820`	Amniocentesis, therapeutic or diagnostic, including ultrasound guidance when performed	Procedure commonly performed to obtain amniotic fluid sample used for `83661` testing.
`59000`	Fetal non-stress test (separate procedure)	Prenatal fetal assessment often performed alongside decisions about fetal lung maturity and timing of delivery.
`80053`	Comprehensive metabolic panel (CMP)	Common laboratory panel ordered during maternal evaluation; performed before or alongside fetal lung maturity testing.
`99499`	Unlisted evaluation and management service	Occasionally used for complex prenatal decision-making visits when no specific E/M code fits the encounter.
`99000`	Handling and/or conveyance of specimen to a laboratory	Ancillary billing for specimen handling that may accompany sample submission for `83661`.

OpenPayer

Summary & Overview